Fate Therapeutics, Inc. (FATE) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$2.07
+5.08%
Mkt Cap $230.79M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $1.34M | $1.37M | +2.42% | -$0.27 | -$0.27 | +0.00% |
| Q4 2025 Nov 13, 2025 | $1.20M | $1.74M | +45.31% | -$0.29 | -$0.27 | +6.90% |
| Q3 2025 Aug 12, 2025 | $1.15M | $1.91M | +65.98% | -$0.35 | -$0.29 | +17.14% |
| Q2 2025 May 13, 2025 | $1.18M | $1.63M | +37.53% | -$0.39 | -$0.32 | +17.95% |
| Q1 2025 Mar 5, 2025 | $1.57M | $1.86M | +18.57% | -$0.44 | -$0.31 | +29.55% |
| Q4 2024 Nov 12, 2024 | $1.32M | $3.07M | +132.88% | -$0.42 | -$0.40 | +4.76% |
| Q3 2024 Aug 13, 2024 | $1.41M | $6.77M | +380.28% | -$0.47 | -$0.33 | +29.79% |
| Q2 2024 May 9, 2024 | $1.11M | $1.93M | +73.42% | -$0.47 | -$0.47 | +0.00% |
| Q1 2024 Feb 26, 2024 | $1.59M | $1.68M | +5.41% | -$0.57 | -$0.45 | +21.05% |
| Q4 2023 Nov 8, 2023 | $1.64M | $1.94M | +18.54% | -$0.59 | -$0.46 | +22.03% |
| Q3 2023 Aug 8, 2023 | $5.53M | $933.00K | -83.13% | -$0.58 | -$0.54 | +6.90% |
| Q2 2023 May 3, 2023 | $35.50M | $58.98M | +66.14% | -$0.55 | -$0.19 | +65.45% |
| Q1 2023 Feb 28, 2023 | $17.88M | $44.36M | +148.07% | -$0.86 | -$0.58 | +32.56% |
| Q4 2022 Nov 3, 2022 | $15.28M | $14.98M | -1.96% | -$0.93 | -$0.86 | +7.53% |
| Q3 2022 Aug 3, 2022 | $12.54M | $18.55M | +47.95% | -$0.86 | -$0.79 | +8.14% |
| Q2 2022 May 4, 2022 | $9.01M | $18.41M | +104.34% | -$0.78 | -$0.68 | +12.82% |
| Q1 2022 Feb 28, 2022 | $11.31M | $17.07M | +50.91% | -$0.68 | -$0.72 | -5.88% |
| Q4 2021 Nov 4, 2021 | $7.89M | $14.22M | +80.29% | -$0.58 | -$0.57 | +1.72% |
| Q3 2021 Aug 4, 2021 | $13.41M | $13.41M | +0.00% | -$0.52 | -$0.58 | -11.54% |
| Q2 2021 May 5, 2021 | $9.85M | $11.14M | +13.16% | -$0.42 | -$0.48 | -14.29% |
| Q1 2021 Feb 24, 2021 | $11.43M | $15.90M | +39.04% | -$0.38 | -$0.38 | +0.00% |
| Q4 2020 Nov 5, 2020 | $7.01M | $7.56M | +7.74% | -$0.29 | -$0.36 | -24.14% |
| Q3 2020 Aug 5, 2020 | $4.22M | $5.46M | +29.63% | -$0.20 | -$0.35 | -75.00% |
| Q2 2020 May 11, 2020 | $2.23M | $2.52M | +12.82% | -$0.38 | -$0.44 | -15.79% |
| Q1 2020 Mar 2, 2020 | $2.95M | $2.80M | -5.13% | -$0.39 | -$0.37 | +5.13% |
| Q4 2019 Nov 5, 2019 | $2.31M | $2.43M | +5.26% | -$0.38 | -$0.40 | -5.26% |
| Q3 2019 Aug 6, 2019 | $2.58M | $2.82M | +9.09% | -$0.32 | -$0.36 | -12.50% |
| Q2 2019 May 7, 2019 | $2.11M | $2.63M | +25.00% | -$0.23 | -$0.30 | -30.43% |
| Q1 2019 Mar 5, 2019 | $1.59M | $1.66M | +4.17% | -$0.23 | -$0.25 | -8.70% |
| Q4 2018 Nov 1, 2018 | $827.42K | $1.03M | +24.00% | -$0.24 | -$0.31 | -29.17% |
| Q3 2018 Aug 6, 2018 | $888.22K | $1.03M | +15.63% | -$0.28 | -$0.37 | -32.14% |
| Q2 2018 May 10, 2018 | $836.00K | $1.03M | +22.73% | -$0.22 | -$0.27 | -22.73% |
| Q1 2018 Mar 5, 2018 | $849.93K | $1.03M | +20.83% | -$0.24 | -$0.29 | -20.83% |
| Q4 2017 Nov 1, 2017 | $947.08K | $1.03M | +8.33% | -$0.25 | -$0.26 | -4.00% |
| Q3 2017 Aug 14, 2017 | $1.07M | $1.03M | -4.17% | -$0.24 | -$0.23 | +4.17% |
| Q2 2017 May 15, 2017 | $855.83K | $1.03M | +20.00% | -$0.21 | -$0.24 | -14.29% |
| Q1 2017 Mar 16, 2017 | $1.42M | $1.03M | -27.59% | -$0.30 | -$0.21 | +30.00% |
| Q4 2016 Nov 7, 2016 | $1.06M | $1.03M | -3.57% | -$0.28 | -$0.27 | +3.57% |
| Q3 2016 Aug 8, 2016 | $1.10M | $1.03M | -6.45% | -$0.31 | -$0.29 | +6.45% |
| Q2 2016 May 9, 2016 | $1.14M | $1.32M | +16.00% | -$0.28 | -$0.29 | -3.57% |
| Q1 2016 Mar 3, 2016 | $1.12M | $1.08M | -3.70% | -$0.27 | -$0.26 | +3.70% |
| Q4 2015 Nov 3, 2015 | $1.28M | $1.03M | -20.00% | -$0.32 | -$0.24 | +25.00% |
| Q3 2015 Aug 5, 2015 | $388.82K | $329.00K | -15.38% | -$0.37 | -$0.33 | +10.81% |
| Q2 2015 May 7, 2015 | — | — | — | -$0.34 | -$0.38 | -11.76% |
| Q1 2015 Mar 12, 2015 | — | — | — | -$0.31 | -$0.30 | +3.23% |
| Q4 2014 Nov 11, 2014 | — | — | — | -$0.29 | -$0.30 | -3.45% |
| Q3 2014 Aug 12, 2014 | — | — | — | -$0.36 | -$0.30 | +16.67% |
| Q2 2014 May 13, 2014 | — | — | — | -$0.32 | -$0.34 | -6.25% |
| Q1 2014 Mar 17, 2014 | $904.03K | -$971.00K | -207.41% | -$0.29 | -$0.29 | +0.00% |
| Q4 2013 Nov 13, 2013 | $2.45M | $209.00K | -91.47% | -$0.37 | -$0.32 | +14.32% |
| Q1 2013 Mar 31, 2013 | — | $472.00K | — | — | -$0.40 | — |
| Q4 2012 Dec 31, 2012 | — | $643.00K | — | — | -$0.47 | — |
| Q3 2012 Sep 30, 2012 | — | $528.00K | — | — | -$0.46 | — |